ACTIVE

ACE PHARMACEUTICALS BELGIUM

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result231,7 k €+332,8 %over 1 year
Gross margin532 k €+92,7 %over 1 year
Equity410,2 k €+129,8 %over 1 year
Workforce1,0 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

ACE PHARMACEUTICALS BELGIUM is a Private limited company incorporated in 2019. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Sint-Martens-Latem. It employs on average 1,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0732.788.379
Incorporation
22/08/2019
Legal form
Private limited company
Registered office
Xavier De Cocklaan 66 box 5
9831 Sint-Martens-Latem · FlandreSee on map
Contributed capital
60 000,00 €
Latest accounts
31/12/2025
Average workforce
1,0 ETP
Signals
ProfitableLow riskPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 6 filings

Trend over 6 financial years

20252024202320222021
Income statement
Gross margin532 k €276 k €150,1 k €140,1 k €209,6 k €
EBITDA408,5 k €169,2 k €43,5 k €32,9 k €100,4 k €
Operating result342,3 k €103,1 k €8,5 k €26 k €98,9 k €
Net result231,7 k €53,5 k €1,6 k €16,7 k €79,6 k €
Balance sheet
Equity410,2 k €178,5 k €125 k €123,3 k €106,6 k €
Total assets1,6 M €1,2 M €1,1 M €184,4 k €168,4 k €
Cash544,3 k €130,9 k €12,3 k €50,4 k €21 k €
Debts1,2 M €1 M €1 M €61,1 k €61,8 k €
Other
Workforce1,0 ETP1,0 ETP1,0 ETP1,0 ETP1,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 6 ended

Active mandates

AMBERSTE HOLDING BV

Director · 0741.457.211

Active
Ronald Feiter CORNELIS

Director

Active
Ronald STEENTJES

Managing director

Active
TLYS

Managing director · 0712.615.151

Represented by Tieme Leyseele

Active

Ended mandates

Edwin Theodoris Maria SLUTTER

Director

Ended
GOLDEN RENNET BV

Managing director · 0732.733.248

Represented by Jan Willem Popma

Ended
MAGISTRAAL BEHEER BV

Director · 0732.733.347

Represented by Jan Verwaal

Ended
Pharmentum

Director · 0699.939.132

Represented by Michaël Hillaert

Ended

Other companies at this address

Xavier De Cocklaan 66 9831 Sint-Martens-Latem
CompanyCBE no.
ACEMAATSCHAP● Active
1039.573.051
CMN● Active
0458.808.614
Gaelens● Active
0842.289.206
G Projects● Active
0454.848.539
IMMO LARCIER● Active
0448.809.003
Mc Three Group● Active
0736.948.194
Mc THREE HOLDINGS● Bankrupt
0450.935.182
SILLAR CLINICAL● Active
0692.746.878
Syndiggit● Active
0681.999.674

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202122/08/2019
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months17 months
Filing date09/07/202629/08/202530/08/202431/08/202330/08/202231/08/2021
General meeting18/06/202619/06/202520/06/202415/06/202316/06/202217/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 6 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202518/06/202609/07/2026DutchPDF
Abridged model31/12/202419/06/202529/08/2025DutchPDF
Abridged model31/12/202320/06/202430/08/2024FrenchPDF
Abridged model31/12/202215/06/202331/08/2023FrenchPDF
Abridged model31/12/202116/06/202230/08/2022FrenchPDF
Abridged model31/12/202017/06/202131/08/2021FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 6 ended

Active mandates

AMBERSTE HOLDING BV

Director · 0741.457.211

Active
Ronald Feiter CORNELIS

Director

Active
Ronald STEENTJES

Managing director

Active
TLYS

Managing director · 0712.615.151

Represented by Tieme Leyseele

Active

Ended mandates

Edwin Theodoris Maria SLUTTER

Director

Ended
GOLDEN RENNET BV

Managing director · 0732.733.248

Represented by Jan Willem Popma

Ended
MAGISTRAAL BEHEER BV

Director · 0732.733.347

Represented by Jan Verwaal

Ended
Pharmentum

Director · 0699.939.132

Represented by Michaël Hillaert

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates25/06/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office22/07/2025
    MAATSCHAPPELIJKE ZETEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Registered office22/07/2025
    SIEGE SOCIAL
    PDF
  • Mandates11/07/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates14/08/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Other26/08/2019
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025231,7 k €↑
  2. 2024
    Annual accounts 202453,5 k €↑
  3. 2023
    Annual accounts 20231,6 k €↓
  4. 2022
    Annual accounts 202216,7 k €↓
  5. 2021
    Annual accounts 202179,6 k €↑
  6. 2020
    Annual accounts 2020-33 k €
  7. 22/08/2019
    IncorporationPrivate limited company